REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dobozpharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DOBOZPHARMA Gyogyszereszeti, Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dobozpharma Bt. is a company in Hungary, with a head office in Doboz. It operates in the Pharmacies and Drug Stores industry. It was incorporated on May 03, 1996. It currently has a total number of 6 (2024) employees. In 2023, the company reported a net sales revenue increase of 3.82%. Its’ total assets recorded a growth of 2.83%. Dobozpharma Bt.’s net profit margin increased by 0.44% in 2023.

Headquarters
Nagy utca 2.
Doboz; Bekes; Postal Code: 5624

Contact Details: Purchase the Dobozpharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dobozpharma Bt. report to view the information.
Outstanding Shares:
Purchase the Dobozpharma Bt. report to view the information.
Registered Capital:
Purchase the Dobozpharma Bt. report to view the information.
Financial Auditors:
Purchase the Dobozpharma Bt. report to view the information.
Incorporation Date:
May 03, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Korosok Volgye Akciocsoport Nonprofit Kft. f.a.
Company Performance
Financial values in the chart are available after Dobozpharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
3.82%▲
Total operating revenue
3.7%▲
Operating profit (EBIT)
20.47%▲
EBITDA
19.98%▲
Net Profit (Loss) for the Period
16.32%▲
Total assets
2.83%▲
Total equity
-13.74%▼
Operating Profit Margin (ROS)
0.65%▲
Net Profit Margin
0.44%▲
Return on Equity (ROE)
8.24%▲
Quick Ratio
0.1%▲
Cash Ratio
0.39%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo